© 2016, TIP ARASTIRMALARI DERNEGI. All rights reserved.Objective: Small cell lung cancer (SCLC) constitutes about 15-25 % of lung cancers with high mortality rate. Herein we observed the effect of parameters at the time of diagnosis to survival of cases with SCLC. Methods: We evaluated 65 patients who were followed up in our oncology department retrospectively. Results: Tumor location and stage at the time of diagnosis, smoking history, accompanying comorbidities, ECOG PS, laboratory parameters and treatments applied in pursuit were evaluated. 3-month survival rate of patients was 75.9%, 50.2% for 6-month, 21.4% for 1 year, and 5.5% for 2 years during follow up. ECOG PS and stage were found statistically significant risk factors in model cr...
Background: Chemotherapy improves survival for many patients with SCLC, and hence it is important to...
BackgroundSmall cell lung cancer (SCLC) is an often lethal disease that commonly occurs in older ind...
Several studies of small cell lung cancer (SCLC) treatments have been performed in the United Kingdo...
Objective: Small-cell lung cancer is a very aggressive tumor associated with high invasiveness and e...
Background: The goal of this study is to examine how small cell lung cancer (SCLC) prognosis and sur...
In order to elucidate factors influencing the prognosis of small-cell lung cancer (SCLC), we reviewe...
OBJECTIVE: The aims of this study were to identify prognostic factors for overall survival (OS) in p...
<p>Lung cancer is the leading cause of cancer-related mortality in both men and women worldwide. Sma...
Background: Small cell lung cancer (SCLC) is an extremely aggressive tumor with a poor clinical cour...
Aim: Evidence supporting improved outcomes for small cell lung cancer (SCLC) in recent decades is li...
BACKGROUND: Predictors of survival and response to treatment in patients with small cell lung cancer...
In this observational study, we assessed treatment patterns and prognostic factors in patients with ...
Lung cancer is the most commonly diagnosed cancer world-wide and the leading cause of cancer death i...
Background: Small cell lung cancer (SCLC) is the most aggressive form of lung cancer. The prognosis ...
This study was conducted to investigate the distribution of metastatic lesions and their influence o...
Background: Chemotherapy improves survival for many patients with SCLC, and hence it is important to...
BackgroundSmall cell lung cancer (SCLC) is an often lethal disease that commonly occurs in older ind...
Several studies of small cell lung cancer (SCLC) treatments have been performed in the United Kingdo...
Objective: Small-cell lung cancer is a very aggressive tumor associated with high invasiveness and e...
Background: The goal of this study is to examine how small cell lung cancer (SCLC) prognosis and sur...
In order to elucidate factors influencing the prognosis of small-cell lung cancer (SCLC), we reviewe...
OBJECTIVE: The aims of this study were to identify prognostic factors for overall survival (OS) in p...
<p>Lung cancer is the leading cause of cancer-related mortality in both men and women worldwide. Sma...
Background: Small cell lung cancer (SCLC) is an extremely aggressive tumor with a poor clinical cour...
Aim: Evidence supporting improved outcomes for small cell lung cancer (SCLC) in recent decades is li...
BACKGROUND: Predictors of survival and response to treatment in patients with small cell lung cancer...
In this observational study, we assessed treatment patterns and prognostic factors in patients with ...
Lung cancer is the most commonly diagnosed cancer world-wide and the leading cause of cancer death i...
Background: Small cell lung cancer (SCLC) is the most aggressive form of lung cancer. The prognosis ...
This study was conducted to investigate the distribution of metastatic lesions and their influence o...
Background: Chemotherapy improves survival for many patients with SCLC, and hence it is important to...
BackgroundSmall cell lung cancer (SCLC) is an often lethal disease that commonly occurs in older ind...
Several studies of small cell lung cancer (SCLC) treatments have been performed in the United Kingdo...